<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>Clinical Trial Design &amp; Power Analysis — clinicaltrialdesign • ClinicoPath</title><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="../deps/bootstrap-5.3.1/bootstrap.min.css" rel="stylesheet"><script src="../deps/bootstrap-5.3.1/bootstrap.bundle.min.js"></script><link href="../deps/font-awesome-6.5.2/css/all.min.css" rel="stylesheet"><link href="../deps/font-awesome-6.5.2/css/v4-shims.min.css" rel="stylesheet"><script src="../deps/headroom-0.11.0/headroom.min.js"></script><script src="../deps/headroom-0.11.0/jQuery.headroom.min.js"></script><script src="../deps/bootstrap-toc-1.0.1/bootstrap-toc.min.js"></script><script src="../deps/clipboard.js-2.0.11/clipboard.min.js"></script><script src="../deps/search-1.0.0/autocomplete.jquery.min.js"></script><script src="../deps/search-1.0.0/fuse.min.js"></script><script src="../deps/search-1.0.0/mark.min.js"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="Clinical Trial Design &amp; Power Analysis — clinicaltrialdesign"><meta name="description" content="Comprehensive power analysis and sample size calculation for clinical trial
design.
Covers the most common clinical trial types with appropriate statistical
tests,
effect size calculations, and regulatory considerations for clinical
research."><meta property="og:description" content="Comprehensive power analysis and sample size calculation for clinical trial
design.
Covers the most common clinical trial types with appropriate statistical
tests,
effect size calculations, and regulatory considerations for clinical
research."></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>


    <nav class="navbar navbar-expand-lg fixed-top bg-light" data-bs-theme="light" aria-label="Site navigation"><div class="container">

    <a class="navbar-brand me-2" href="../index.html">ClinicoPath</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">0.0.32.72</small>


    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="nav-item"><a class="nav-link" href="../dev/index.html"><span class="fa fa-cogs"></span></a></li>
<li class="active nav-item"><a class="nav-link" href="../reference/index.html">Reference</a></li>
<li class="nav-item"><a class="nav-link" href="../articles/index.html">Articles</a></li>
<li class="nav-item dropdown">
  <button class="nav-link dropdown-toggle" type="button" id="dropdown-test-data" data-bs-toggle="dropdown" aria-expanded="false" aria-haspopup="true"><span class="fa fa-database"></span> Test Data</button>
  <ul class="dropdown-menu" aria-labelledby="dropdown-test-data"><li><a class="dropdown-item" href="../articles/test-data-catalog.html">Test Data Catalog</a></li>
    <li><a class="dropdown-item" href="../articles/test-data-complete-catalog.html">Complete Catalog (945 files)</a></li>
    <li><a class="dropdown-item" href="../articles/function-reference.html">Function Reference</a></li>
  </ul></li>
<li class="nav-item"><a class="nav-link" href="../news/index.html">Changelog</a></li>
      </ul><ul class="navbar-nav"><li class="nav-item"><a class="external-link nav-link" href="http://twitter.com/serdarbalci"><span class="fa fab fa-twitter fa-lg"></span></a></li>
<li class="nav-item"><a class="external-link nav-link" href="https://github.com/sbalci/ClinicoPathJamoviModule/" aria-label="GitHub"><span class="fa fab fa-github fa-lg"></span></a></li>
      </ul></div>


  </div>
</nav><div class="container template-reference-topic">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">

      <h1>Clinical Trial Design &amp; Power Analysis</h1>
      <small class="dont-index">Source: <a href="https://github.com/sbalci/ClinicoPathJamoviModule/blob/HEAD/R/clinicaltrialdesign.h.R" class="external-link"><code>R/clinicaltrialdesign.h.R</code></a></small>
      <div class="d-none name"><code>clinicaltrialdesign.Rd</code></div>
    </div>

    <div class="ref-description section level2">
    <p>Comprehensive power analysis and sample size calculation for clinical trial
design.
Covers the most common clinical trial types with appropriate statistical
tests,
effect size calculations, and regulatory considerations for clinical
research.</p>
    </div>

    <div class="section level2">
    <h2 id="ref-usage">Usage<a class="anchor" aria-label="anchor" href="#ref-usage"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="fu">clinicaltrialdesign</span><span class="op">(</span></span>
<span>  <span class="va">data</span>,</span>
<span>  trial_type <span class="op">=</span> <span class="st">"superiority"</span>,</span>
<span>  outcome_type <span class="op">=</span> <span class="st">"continuous"</span>,</span>
<span>  test_type <span class="op">=</span> <span class="st">"two_sample_ttest"</span>,</span>
<span>  calculation_type <span class="op">=</span> <span class="st">"sample_size"</span>,</span>
<span>  alpha <span class="op">=</span> <span class="fl">0.05</span>,</span>
<span>  power <span class="op">=</span> <span class="fl">0.8</span>,</span>
<span>  sample_size <span class="op">=</span> <span class="fl">100</span>,</span>
<span>  effect_size <span class="op">=</span> <span class="fl">0.5</span>,</span>
<span>  mean_difference <span class="op">=</span> <span class="fl">1</span>,</span>
<span>  common_sd <span class="op">=</span> <span class="fl">2</span>,</span>
<span>  proportion1 <span class="op">=</span> <span class="fl">0.3</span>,</span>
<span>  proportion2 <span class="op">=</span> <span class="fl">0.5</span>,</span>
<span>  allocation_ratio <span class="op">=</span> <span class="fl">1</span>,</span>
<span>  two_sided <span class="op">=</span> <span class="cn">TRUE</span>,</span>
<span>  continuity_correction <span class="op">=</span> <span class="cn">TRUE</span>,</span>
<span>  margin <span class="op">=</span> <span class="fl">0.1</span>,</span>
<span>  margin_type <span class="op">=</span> <span class="st">"absolute"</span>,</span>
<span>  dropout_rate <span class="op">=</span> <span class="fl">10</span>,</span>
<span>  interim_analyses <span class="op">=</span> <span class="fl">0</span>,</span>
<span>  multiple_comparisons <span class="op">=</span> <span class="st">"none"</span>,</span>
<span>  show_assumptions <span class="op">=</span> <span class="cn">TRUE</span>,</span>
<span>  show_interpretation <span class="op">=</span> <span class="cn">TRUE</span>,</span>
<span>  show_sensitivity <span class="op">=</span> <span class="cn">TRUE</span>,</span>
<span>  show_plots <span class="op">=</span> <span class="cn">TRUE</span>,</span>
<span>  regulatory_context <span class="op">=</span> <span class="st">"ich"</span></span>
<span><span class="op">)</span></span></code></pre></div>
    </div>

    <div class="section level2">
    <h2 id="arguments">Arguments<a class="anchor" aria-label="anchor" href="#arguments"></a></h2>


<dl><dt id="arg-data">data<a class="anchor" aria-label="anchor" href="#arg-data"></a></dt>
<dd><p>the data as a data frame (optional for power calculations)</p></dd>


<dt id="arg-trial-type">trial_type<a class="anchor" aria-label="anchor" href="#arg-trial-type"></a></dt>
<dd><p>Type of clinical trial design for appropriate power
calculations</p></dd>


<dt id="arg-outcome-type">outcome_type<a class="anchor" aria-label="anchor" href="#arg-outcome-type"></a></dt>
<dd><p>Type of primary outcome variable determining
appropriate statistical test</p></dd>


<dt id="arg-test-type">test_type<a class="anchor" aria-label="anchor" href="#arg-test-type"></a></dt>
<dd><p>Statistical test appropriate for the outcome type and
study design</p></dd>


<dt id="arg-calculation-type">calculation_type<a class="anchor" aria-label="anchor" href="#arg-calculation-type"></a></dt>
<dd><p>What to calculate - power, sample size, or
detectable effect size</p></dd>


<dt id="arg-alpha">alpha<a class="anchor" aria-label="anchor" href="#arg-alpha"></a></dt>
<dd><p>Significance level (typically 0.05 for superiority, 0.025 for
non-inferiority)</p></dd>


<dt id="arg-power">power<a class="anchor" aria-label="anchor" href="#arg-power"></a></dt>
<dd><p>Desired statistical power (typically 0.80 or 0.90)</p></dd>


<dt id="arg-sample-size">sample_size<a class="anchor" aria-label="anchor" href="#arg-sample-size"></a></dt>
<dd><p>Total sample size for power calculation</p></dd>


<dt id="arg-effect-size">effect_size<a class="anchor" aria-label="anchor" href="#arg-effect-size"></a></dt>
<dd><p>Standardized effect size (Cohen's d for continuous
outcomes)</p></dd>


<dt id="arg-mean-difference">mean_difference<a class="anchor" aria-label="anchor" href="#arg-mean-difference"></a></dt>
<dd><p>Expected difference in means between groups</p></dd>


<dt id="arg-common-sd">common_sd<a class="anchor" aria-label="anchor" href="#arg-common-sd"></a></dt>
<dd><p>Pooled standard deviation for continuous outcomes</p></dd>


<dt id="arg-proportion-">proportion1<a class="anchor" aria-label="anchor" href="#arg-proportion-"></a></dt>
<dd><p>Expected proportion in control/reference group</p></dd>


<dt id="arg-proportion-">proportion2<a class="anchor" aria-label="anchor" href="#arg-proportion-"></a></dt>
<dd><p>Expected proportion in treatment/experimental group</p></dd>


<dt id="arg-allocation-ratio">allocation_ratio<a class="anchor" aria-label="anchor" href="#arg-allocation-ratio"></a></dt>
<dd><p>Ratio of treatment to control group sizes (1 =
equal allocation)</p></dd>


<dt id="arg-two-sided">two_sided<a class="anchor" aria-label="anchor" href="#arg-two-sided"></a></dt>
<dd><p>Use two-sided statistical test (recommended for most
trials)</p></dd>


<dt id="arg-continuity-correction">continuity_correction<a class="anchor" aria-label="anchor" href="#arg-continuity-correction"></a></dt>
<dd><p>Apply continuity correction for proportion
tests</p></dd>


<dt id="arg-margin">margin<a class="anchor" aria-label="anchor" href="#arg-margin"></a></dt>
<dd><p>Non-inferiority or equivalence margin (absolute difference)</p></dd>


<dt id="arg-margin-type">margin_type<a class="anchor" aria-label="anchor" href="#arg-margin-type"></a></dt>
<dd><p>Type of margin for non-inferiority/equivalence testing</p></dd>


<dt id="arg-dropout-rate">dropout_rate<a class="anchor" aria-label="anchor" href="#arg-dropout-rate"></a></dt>
<dd><p>Expected dropout/loss to follow-up rate for sample size
inflation</p></dd>


<dt id="arg-interim-analyses">interim_analyses<a class="anchor" aria-label="anchor" href="#arg-interim-analyses"></a></dt>
<dd><p>Number of planned interim analyses (affects alpha
spending)</p></dd>


<dt id="arg-multiple-comparisons">multiple_comparisons<a class="anchor" aria-label="anchor" href="#arg-multiple-comparisons"></a></dt>
<dd><p>Adjustment for multiple testing (when
applicable)</p></dd>


<dt id="arg-show-assumptions">show_assumptions<a class="anchor" aria-label="anchor" href="#arg-show-assumptions"></a></dt>
<dd><p>Display assumptions for the selected statistical
test</p></dd>


<dt id="arg-show-interpretation">show_interpretation<a class="anchor" aria-label="anchor" href="#arg-show-interpretation"></a></dt>
<dd><p>Include clinical interpretation and regulatory
considerations</p></dd>


<dt id="arg-show-sensitivity">show_sensitivity<a class="anchor" aria-label="anchor" href="#arg-show-sensitivity"></a></dt>
<dd><p>Perform sensitivity analysis across parameter
ranges</p></dd>


<dt id="arg-show-plots">show_plots<a class="anchor" aria-label="anchor" href="#arg-show-plots"></a></dt>
<dd><p>Generate power/sample size relationship plots</p></dd>


<dt id="arg-regulatory-context">regulatory_context<a class="anchor" aria-label="anchor" href="#arg-regulatory-context"></a></dt>
<dd><p>Regulatory context for power analysis
considerations</p></dd>

</dl></div>
    <div class="section level2">
    <h2 id="value">Value<a class="anchor" aria-label="anchor" href="#value"></a></h2>
    <p>A results object containing:</p><table class="table table"><tr><td><code>results$instructions</code></td><td></td><td></td><td></td><td></td><td>Instructions for clinical trial design and power analysis</td></tr><tr><td><code>results$design_summary</code></td><td></td><td></td><td></td><td></td><td>Summary of trial design parameters and recommendations</td></tr><tr><td><code>results$power_results</code></td><td></td><td></td><td></td><td></td><td>Primary power analysis calculations and results</td></tr><tr><td><code>results$sample_size_breakdown</code></td><td></td><td></td><td></td><td></td><td>Detailed sample size calculations with adjustments</td></tr><tr><td><code>results$effect_size_analysis</code></td><td></td><td></td><td></td><td></td><td>Effect size calculations and clinical significance assessment</td></tr><tr><td><code>results$assumptions_check</code></td><td></td><td></td><td></td><td></td><td>Key assumptions for the selected statistical test</td></tr><tr><td><code>results$sensitivity_analysis</code></td><td></td><td></td><td></td><td></td><td>Power/sample size sensitivity across parameter ranges</td></tr><tr><td><code>results$regulatory_considerations</code></td><td></td><td></td><td></td><td></td><td>Regulatory guidance and compliance considerations</td></tr><tr><td><code>results$power_curve</code></td><td></td><td></td><td></td><td></td><td>Power curves showing relationship between sample size and statistical power</td></tr><tr><td><code>results$effect_size_plot</code></td><td></td><td></td><td></td><td></td><td>Effect size distribution and clinical significance thresholds</td></tr><tr><td><code>results$sample_size_plot</code></td><td></td><td></td><td></td><td></td><td>Sample size requirements across different effect sizes and power levels</td></tr><tr><td><code>results$clinical_interpretation</code></td><td></td><td></td><td></td><td></td><td>Clinical context, interpretation guidelines, and next steps</td></tr><tr><td><code>results$study_protocol_template</code></td><td></td><td></td><td></td><td></td><td>Template sections for study protocol statistical analysis plan</td></tr></table><p>Tables can be converted to data frames with <code>asDF</code> or <code><a href="https://rdrr.io/r/base/as.data.frame.html" class="external-link">as.data.frame</a></code>. For example:</p>
<p><code>results$design_summary$asDF</code></p>
<p><code>as.data.frame(results$design_summary)</code></p>
    </div>
    <div class="section level2">
    <h2 id="details">Details<a class="anchor" aria-label="anchor" href="#details"></a></h2>
    <p>Supports randomized controlled trials (RCTs), equivalence trials,
non-inferiority
trials, superiority trials, and observational studies with proper power
calculations.</p>
    </div>

    <div class="section level2">
    <h2 id="ref-examples">Examples<a class="anchor" aria-label="anchor" href="#ref-examples"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span class="r-in"><span><span class="fu"><a href="https://rdrr.io/r/utils/data.html" class="external-link">data</a></span><span class="op">(</span><span class="st">'your_data'</span><span class="op">)</span></span></span>
<span class="r-wrn co"><span class="r-pr">#&gt;</span> <span class="warning">Warning: </span>data set ‘your_data’ not found</span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="fu">clinicaltrialdesign</span><span class="op">(</span></span></span>
<span class="r-in"><span>    trial_type <span class="op">=</span> <span class="st">"superiority"</span>,</span></span>
<span class="r-in"><span>    outcome_type <span class="op">=</span> <span class="st">"continuous"</span>,</span></span>
<span class="r-in"><span>    test_type <span class="op">=</span> <span class="st">"two_sample_ttest"</span>,</span></span>
<span class="r-in"><span>    effect_size <span class="op">=</span> <span class="fl">0.5</span>,</span></span>
<span class="r-in"><span>    alpha <span class="op">=</span> <span class="fl">0.05</span>,</span></span>
<span class="r-in"><span>    power <span class="op">=</span> <span class="fl">0.80</span></span></span>
<span class="r-in"><span><span class="op">)</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  CLINICAL TRIAL DESIGN &amp; POWER ANALYSIS</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  &lt;p style='color: red;'&gt;Analysis Error: 'isVisible' does not exist in</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  this results element</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Trial Design Summary                                                                                                                                                               </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    Design Parameter           Selected Value      Recommendation                                                  Rationale                                                         </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    Trial Design Type          superiority         Superiority trial - demonstrates new treatment is better        Determines statistical approach and regulatory requirements       </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    Primary Outcome Type       continuous          Continuous outcome - use parametric tests if assumptions met    Determines appropriate statistical test and effect size measure   </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    Statistical Test           two_sample_ttest    Compare means between two independent groups                    Standard test for continuous outcomes in RCTs                     </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    Significance Level (α)           0.05000000    Standard α=0.05 appropriate for superiority trials              Balances Type I error risk with study feasibility                 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    Statistical Power (1-β)          0.80000000    Adequate power (80-89%) - standard for most trials              Higher power reduces risk of missing true effects                 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Power Analysis Results                                                                                                                     </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    Parameter                     Input Value    Calculated Value    95% CI    Interpretation                                                </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    Required Sample Size                         256                           Large study - high power but requires substantial resources   </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    Statistical Power (Input)     0.8                                          Desired power for sample size calculation                     </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    Effect Size (Input)           0.5                                          Expected effect size based on literature or pilot data        </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    Significance Level (Input)    0.05                                         Type I error rate for hypothesis testing                      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Sample Size Breakdown                                                                                                                </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    Sample Size Component       Per Group          Total      Adjustment Factor    Rationale                                           </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    Base Sample Size                  128 / 128        256            1.0000000    Statistical power requirement without adjustments   </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    Dropout Adjustment                143 / 143        285            1.1111111    Accounts for 10% expected dropout rate              </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    **Final Recommendation**    ** 143 / 143 **    **285**            0.8949559    Total sample size including all adjustments         </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Effect Size Analysis                                                                                                                                                           </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    Effect Measure     Value        Magnitude                          Clinical Significance                                       Statistical Significance                      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    Cohen's d          0.5000000    Medium effect                      Likely clinically meaningful                                Depends on sample size and alpha level        </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    Mean Difference    1.0000000    Raw difference in outcome units    Evaluate against minimal clinically important difference    Raw effect size for clinical interpretation   </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Statistical Assumptions                                                                                                                                                                                </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    Assumption         Description                                          Assessment Method                             Impact if Violated                      Alternative Tests                      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    Normality          Data should be approximately normally distributed    Shapiro-Wilk test, Q-Q plots, histograms      Inflated Type I error, reduced power    Wilcoxon tests, Bootstrap methods      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    Independence       Observations should be independent                   Study design review, clustering assessment    Severely inflated Type I error          Mixed-effects models, GEE              </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    Equal Variances    Groups should have similar variances (two-sample)    Levene's test, F-test                         Type I error inflation                  Welch's t-test, non-parametric tests   </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Sensitivity Analysis                                                                                                                  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    Parameter             Low Value     Base Value    High Value    Impact Assessment                                                   </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    Effect Size           0.37500000    0.50000000     0.6250000    25% change in effect size significantly impacts power/sample size   </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    Statistical Power     0.70000000    0.80000000     0.9000000    10% power change moderately impacts required sample size            </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    Significance Level    0.02500000    0.05000000     0.1000000    More stringent alpha increases required sample size                 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    Dropout Rate (%)      5%            10%           20%           Higher dropout rates require substantial sample size inflation      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Regulatory Considerations                                                                                                                                                                            </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    Regulatory Aspect    Requirement/Guideline                                    Compliance Status    Recommendation                                         Reference                                </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    Statistical Power    ≥80% power recommended, ≥90% for pivotal trials          Compliant            Consider increasing power for regulatory submission    FDA Statistical Guidance (2018)          </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    Multiple Testing     Control family-wise error rate for multiple endpoints    Needs Attention      Implement appropriate multiplicity adjustments         FDA Multiple Endpoints Guidance (2017)   </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  &lt;meta http-equiv='Content-Type' content='text/html; charset=UTF-8'&gt;</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Clinical Trial Design - Interpretation &amp; Guidelines</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Study Design Summary</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Trial Type: superiority trial with continuous primary outcome</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Statistical Approach: two_sample_ttest with α=0.05 and power=0.8</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Sample Size Interpretation</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  The calculated sample size ensures adequate statistical power to</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  detect clinically meaningful differences. Consider the following</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  factors in your interpretation:</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Effect Size: Based on Cohen's d - ensure this represents a clinically</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  meaningful changeFeasibility: Assess recruitment capacity and timeline</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  constraintsDropout Adjustment: 10% dropout rate assumed - monitor</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  closely during studyInterim Analyses: No interim analyses planned -</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  consider for long studies</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Clinical Significance</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Minimal Clinically Important Difference (MCID): Ensure your effect</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  size aligns with established MCID values from literature. The</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  statistical significance should be accompanied by clinical relevance</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  assessment.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Regulatory Considerations</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Regulatory Context: ich guidelines considered</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Ensure pre-specification of all analyses in protocolConsider</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  regulatory precedent for similar indicationsPlan for sensitivity</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  analyses and robustness assessments</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Study Conduct Recommendations</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Randomization: Use appropriate randomization scheme (stratified,</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  blocked, adaptive)Blinding: Implement double-blinding when feasible</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  for outcome assessmentData Monitoring: Establish independent DSMB for</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  safety and efficacy monitoringQuality Assurance: Plan for data quality</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  monitoring and source data verificationAnalysis Plan: Develop detailed</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  statistical analysis plan before database lock</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Next Steps</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Validate sample size assumptions with pilot data or literature</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  reviewDevelop comprehensive study protocol with statistical analysis</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  planConsider adaptive design elements if appropriatePlan for</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  regulatory interactions (pre-IND, Type C meetings)Establish study</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  infrastructure and monitoring procedures</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  &lt;meta http-equiv='Content-Type' content='text/html; charset=UTF-8'&gt;</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Study Protocol - Statistical Analysis Plan Template</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  9. STATISTICAL CONSIDERATIONS</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  9.1 Study Design</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  This is a superiority trial designed to evaluate [intervention]</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  compared to [control] with respect to [primary outcome]. The study</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  follows a randomized, controlled design with 1:1 randomization.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  9.2 Sample Size Calculation</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Primary Outcome: continuous outcome analyzed using two_sample_ttest</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Statistical Parameters:</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Type I error rate (α): 0.05Statistical power (1-β): 0.8Effect size:</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Cohen's d = 0.5Two-sided testing: Yes</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Sample Size Justification: Based on [literature/pilot data reference],</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  we expect [effect size rationale]. With the specified parameters, the</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  calculated sample size provides adequate power to detect clinically</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  meaningful differences.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  9.3 Randomization and Blinding</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  [Describe randomization scheme, stratification factors, and blinding</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  procedures]</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  9.4 Statistical Analysis Plan</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Primary Analysis: two_sample_ttest will be used to compare [outcome]</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  between treatment groups. Analysis will follow the intention-to-treat</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  principle.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Secondary Analyses:</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Per-protocol analysis for sensitivity assessmentSubgroup analyses for</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  [specify subgroups]Safety analyses (all randomized subjects)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  9.6 Missing Data</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Missing data will be minimized through [specify procedures]. For</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  primary analysis, [specify approach - complete case, multiple</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  imputation, etc.]. Sensitivity analyses will assess robustness to</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  missing data assumptions.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  9.7 Multiple Testing</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  No adjustment for multiple testing planned for primary endpoint.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  Secondary endpoints will be considered exploratory.</span>
<span class="r-err co"><span class="r-pr">#&gt;</span> <span class="error">Error:</span> no render function</span>
<span class="r-in"><span></span></span>
</code></pre></div>
    </div>
  </main><aside class="col-md-3"><nav id="toc" aria-label="Table of contents"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="pkgdown-footer-left">
  <p>Developed by <a href="https://www.serdarbalci.com/" class="external-link">Serdar Balci</a>.</p>
</div>

<div class="pkgdown-footer-right">
  <p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.1.3.</p>
</div>

    </footer></div>





  </body></html>

